US 12358979
Antibodies that bind interleukin 13 and methods of use
granted A61KA61K2039/505
Quick answer
US patent 12358979 (Antibodies that bind interleukin 13 and methods of use) held by Apogee Therapeutics, Inc. expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apogee Therapeutics, Inc.
- Grant date
- Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505